This Fund aims to provide a monthly income rising over time together with capital growth by investing predominantly in a combination of UK equities and fixed income securities. The Authorised Corporate Director may also invest at its discretion in other transferable securities, money market instruments, deposits, cash and near cash and collective investment schemes.
Name | % Net Assets |
---|---|
1. HSBC Holdings PLC (UK Reg) | 4.2% |
Vodafone Group | 3.6% |
GlaxoSmithKline | 3.6% |
Vodafone Group | 3.6% |
HSBC Holdings PLC (UK Reg) | 3.3% |
British American Tobacco | 2.9% |
Royal Dutch Shell B | 2.8% |
4¾% Treasury Stock 2038 | 2.2% |
Diageo | 1.9% |
4¼% Treasury Gilt 2046 | 1.8% |
Key | % Net Assets |
---|---|
1. HSBC Holdings PLC (UK Reg) | 4.2% |
Vodafone Group | 3.6% |
GlaxoSmithKline | 3.6% |
Vodafone Group | 3.6% |
Other | 85% |
Date | 17-Dec-2021 |
---|---|
NAV | 313.40p |
Currency | GBP |
Change | 0.80p |
% | 0.26% |
YTD change | 313.40p |
YTD % | n/a |
Fund Inception | 05/01/1994 |
---|---|
Fund Manager | Opkar Sara |
TER | 1.40 (15-Jan-2012) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | £500 |
Savings | £50 |
Charges | |
---|---|
Initial | 4.00% |
Annual Mang't | 1.25% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.06 |
You are here: research